nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

08.08.2023 | Review

Breast cancer in young Indian women: factors, challenges in screening, and upcoming diagnostics

verfasst von: Pragyan Roy

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 15/2023

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer management for young Indian women are full of challenges. The National Cancer Registry Programme (NCRP) has predicted that nearly 2,30,000 cases of breast cancer will be reported annually by 2025; with a steady increase in cases of young women (< 45 years of age) with breast cancer. In this review, the available literature is evaluated to understand the various risk factors contributing to the rise in cases of breast cancer in young women in India. Further, the challenges that are faced by the technicians in early diagnosis (e.g., physiology of young breasts, limited trained professionals, and awareness among patients, and cost of the treatment) of breast cancer. This review also focuses on the upcoming diagnostics like serum biomarkers and nanosensors for the early identification of the disease. For better prognosis and to reduce the chances of disease reoccurrence and metastasis, it is important that the disease has to be identified at an early stage.

Graphical abstract

Ajaikumar BS, Rao R, Prabhu J, Kulkarni JD, Patil PK, Babu C et al (2009) The prognostic importance of triple negative breast cancer: a population based study in India. J Clin Oncol 27:e22219CrossRef

Akhtar M, Dasgupta S, Rangwala M (2015) Triple negative breast cancer: an Indian perspective. Breast Cancer (dove Medical Press) 7:239–243. https://doi.org/10.2147/bctt.s85442CrossRefPubMed

Al Joudi FS (2014) Human mammaglobin in breast cancer: a brief review of its clinical utility. Indian J Med Res 139(05):675–685PubMedPubMedCentral

Antony M, Surakutty B, Vasu T, Chisthi M (2018) Risk factors for breast cancer among Indian women: a case; control study. Niger J Clin Pract 21(4):436–442CrossRefPubMed

Bajpai J, Ventrapati P, Joshi S, Wadasadawala T, Rath S, Pathak R, Nandhana R, Mohanty S, Chougle Q, Engineer M, Abraham N, Ghosh J, Nair N, Gulia S, Popat P, Sheth T, Desai S, Thakur M, Rangrajan V, Parmar V, Sarin R, Gupta S, Badwe RA (2021) Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India. Breast 60:177–184. https://doi.org/10.1016/j.breast.2021.09.008CrossRefPubMedPubMedCentral

Baltzer P, Mann RM, Iima M, Sigmund EE, Clauser P, Gilbert FJ, Martincich L, Partridge SC, Patterson A, Pinker K et al (2020) Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol 30:1436–1450. https://doi.org/10.1007/s00330-019-06510-3CrossRefPubMed

Berg WA (2016) Current status of supplemental screening in dense breasts. J Clin Oncol 34(16):1840–1843. https://doi.org/10.1200/JCO.2015.65.8674CrossRefPubMed

Blumen H, Fitch K, Polkus V (2016) Comparison of treatment costs for breast cancer, by tumor stage and type of service. Am Health Drug Benefits 9:23–32PubMedPubMedCentral

Chen L, Bourguignon LY (2014) Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells. Mol Cancer 13:52CrossRefPubMedPubMedCentral

Cong Y, Cui Y, Wang S, Jiang L, Cao J, Zhu S, Birkin E, Lane J, Ruge F, Jiang WG, Qiao G (2020) Calcium-binding protein S100P promotes tumor progression but enhances chemosensitivity in breast cancer. Front Oncol 10:566302. https://doi.org/10.3389/fonc.2020.566302CrossRefPubMedPubMedCentral

Dall GV, Britt KL (2017) Estrogen effects on the mammary gland in early and late life and breast cancer risk. Front Oncol. https://doi.org/10.3389/fonc.2017.00110CrossRefPubMedPubMedCentral

Dave H, Shah M, Trivedi S, Shukla S (2012) Prognostic utility of circulating transforming growth factor beta 1 in breast cancer patients. Int J Biol Markers 27(1):53–59. https://doi.org/10.5301/JBM.2011.8736CrossRefPubMed

De Santis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics, 2011. CA Cancer J Clin 61:409–418

Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA et al (2007) Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res 13:4429–4434CrossRefPubMed

Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A (2009) Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum. South India Int J Cancer 125:1663–1670CrossRefPubMed

Do Hwang W, Ko H, Lee JH et al (2010) A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med 51(1):98–105CrossRefPubMed

Economopoulos V, Chen Y, McFadden C, Foster PJ (2013) MRI detection of nonproliferative tumor cells in lymph node metastases using iron oxide particles in a mouse model of breast cancer. Transl Oncol 6(3):347–354. https://doi.org/10.1593/tlo.13121CrossRefPubMedPubMedCentral

Feri N, Bachtiar BM, Desak SG (2022) The correlation of fibronectin and vimentin expression on anthracycline-based neoadjuvant chemotherapy response in stage IIIA and luminal subtype IIIB breast cancer. Biomol Health Sci J 5(2):88–92. https://doi.org/10.4103/bhsj.bhsj_25_22CrossRef

Fortner RT, Sisti J, Chai B et al (2019) Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses’ Health Studies. Breast Cancer Res 21:40. https://doi.org/10.1186/s13058-019-1119-yCrossRefPubMedPubMedCentral

Garczyk S, von Stillfried S, Antonopoulos W, Hartmann A, Schrauder MG, Fasching PA et al (2015) AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection. PLoS ONE 10(4):e0122106. https://doi.org/10.1371/journal.pone.0122106CrossRefPubMedPubMedCentral

Greten FR, Karin M (2004) The IKK/NF-κB activation pathway-a target for prevention. Cancer Lett 206:193–199CrossRefPubMed

Hao W, Zhang X, Xiu B et al (2016) Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients. Tumor Biol 37(7):8909–8916CrossRef

Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251:499–505. https://doi.org/10.1097/SLA.0b013e3181cc939fCrossRefPubMed

Huang ZX, Xie Q, Guo QP, Wang KM, Meng XX, Yuan BY et al (2017) DNA aptamer selected for specific recognition of prostate cancer cells and clinical tissues. Chinese Chem Lett 28(6):1252–1257. https://doi.org/10.1016/j.cclet.2017.01.002CrossRef

India State-Level Disease Burden Initiative Cancer Collaborators (2018) The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Oncol 19:1289–1306CrossRef

India State-Level Disease Burden Initiative Diabetes Collaborators (2018) The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. https://doi.org/10.1016/S2214-109X(18)30387-5CrossRef

Ishibashi Y, Ohtsu H, Ikemura M, Kikuchi Y, Niwa T, Nishioka K et al (2017) Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer. Sci Rep 7(1):4846–4910. https://doi.org/10.1038/s41598-017-05129-yCrossRefPubMedPubMedCentral

Jahani S, Nazeri E, Majidzadeh AK, Jahani M, Esmaeili R (2020) Circular RNA; a new biomarker for breast cancer: a systematic review. J Cell Physiol 235:5501–5510. https://doi.org/10.1002/jcp.29558CrossRefPubMed

Jana D, Sarkar DK, Ganguly S, Saha S, Sa G, Manna AK, Banerjee A, Mandal S (2014) Role of cyclooxygenase 2 (COX-2) in prognosis of breast cancer. Indian J Surg Oncol 5(1):59–65. https://doi.org/10.1007/s13193-014-0290-yCrossRefPubMedPubMedCentral

Jeon T, Kim YS, Son HM, Lee SE (2022) Tips for finding magnetic resonance imaging-detected suspicious breast lesions using second-look ultrasonography: a pictorial essay. Ultrasonography 41(3):624–632. https://doi.org/10.14366/usg.21219CrossRefPubMedPubMedCentral

Jonnada PK, Sushma C, Karyampudi M, Dharanikota A (2021) Prevalence of molecular subtypes of breast cancer in India: a systematic review and meta-analysis. Indian J Surg Oncol 12(Suppl 1):152–163. https://doi.org/10.1007/s13193-020-01253-wCrossRefPubMed

Kathrikolly T, Nair SN, Mathew A et al (2022) Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis. Syst Rev 11:215. https://doi.org/10.1186/s13643-022-02088-yCrossRefPubMedPubMedCentral

Khodarahmi M, Azadbakht L (2014) The association between different kinds of fat intake and breast cancer risk in women. Int J Prev Med 5:1–6

Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ (2014) Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. Mol Oncol 8:874–883. https://doi.org/10.1016/j.molonc.2014.03.002CrossRefPubMedPubMedCentral

Kulkarni A, Kelkar DA, Parikh N et al (2020) Meta-analysis of prevalence of triple-negative breast cancer and its clinical features at incidence in Indian patients with breast cancer. JCO Global Oncology 6:1052–1062. https://doi.org/10.1200/go.20.00054CrossRefPubMed

Kumar N, Patni P, Agarwal A, Khan MA, Parashar N (2015) Prevalence of molecular subtypes of invasive breast cancer: a retrospective study. Med J Armed Forces India 71(3):254–258. https://doi.org/10.1016/j.mjafi.2015.04.006CrossRefPubMedPubMedCentral

Leong SPL, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, Sandelin K, Derossis A, Cody H, Foulkes WD (2010) Is breast cancer the same disease in Asian and western countries? World J Surg 34:2308–2324. https://doi.org/10.1007/s00268-010-0683-1CrossRefPubMedPubMedCentral

Li Y, Zheng J, Deng Y, Deng X, Lou W, Wei B, Xiang D, Hu J, Zheng Y, Xu P, Yao J, Zhai Z, Zhou L, Yang S, Wu Y, Kang H, Dai Z (2022) Global burden of female breast cancer: age-period-cohort analysis of incidence trends from 1990 to 2019 and forecasts for 2035. Front Oncol 12:891824. https://doi.org/10.3389/fonc.2022.891824CrossRefPubMedPubMedCentral

Liu Y, Nguyen N, Colditz GA (2015) Links between alcohol consumption and breast cancer: a look at the evidence. Women’s Health 11:65PubMed

Logozzi M, Mizzoni D, Di Raimo R, Fais S (2020) Exosomes: a source for new and old biomarkers in cancer. Cancers 12:2566. https://doi.org/10.3390/cancers12092566CrossRefPubMedPubMedCentral

Loh H-Y, Norman BP, Lai K-S, Rahman NMANA, Alitheen NBM, Osman MA (2019) The regulatory role of MicroRNAs in breast cancer. Int J Mol Sci 20(19):4940. https://doi.org/10.3390/ijms20194940CrossRefPubMedPubMedCentral

Ma J, Kong Y, Nan H et al (2017) Pleiotrophin as a potential biomarker in breast cancer patients. Clin Chim Acta 466:6–12CrossRefPubMed

Malvia S, Bagadi SA, Dubey US, Saxena S (2017) Epidemiology of breast cancer in Indian women. Asia Pac J Clin Oncol. https://doi.org/10.1111/ajco.12661CrossRefPubMed

Mathew A, Gajalakshmi V, Rajan B, Kanimozhi VC, Brennan P, Binukumar BP et al (2009) Physical activity levels among urban and rural women in south India and the risk of breast cancer: a case-control study. Eur J Cancer Prev 18:368–376. https://doi.org/10.1097/CEJ.0b013e32832e1c46CrossRefPubMed

Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Selvaraj FR (2020) Cancer statistics 2020: report from National Cancer Registry Programme, India. JCO Glob Oncol 6:1063–1075. https://doi.org/10.1200/GO.20.00122CrossRefPubMed

McDonald JA, Rao R, Gibbons M et al (2021) Symposium report: breast cancer in India—trends, environmental exposures and clinical implications. Cancer Causes Control 32:567–575. https://doi.org/10.1007/s10552-021-01428-yCrossRefPubMedPubMedCentral

Michel SCA, Keller TM, Fröhlich JM, Fink D, Caduff R, Seifert B, Marincek B, Kubik-Huch RA (2002) Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 225:527–536. https://doi.org/10.1148/radiol.2252011605CrossRefPubMed

Mohite V, Pratinidhi A, Mohite R (2014) Dietary factors and breast cancer: a case control study from rural India. Asian J Med Sci 6(1):55–60. https://doi.org/10.3126/ajms.v6i1.10285CrossRef

Mousavi-Jarrrahi SH, Kasaeian A, Mansori K, Ranjbaran M, Khodadost M, Mosavi-Jarrahi A (2013) Addressing the younger age at onset in breast cancer patients in Asia: an age-period-cohort analysis of fifty years of quality data from the international agency for research on cancer. ISRN Oncol 2013:429862. https://doi.org/10.1155/2013/429862CrossRefPubMedPubMedCentral

Niehoff N, White AJ, McCullough LE, Steck SE, Beyea J, Mordukhovich I, Shen J, Neugut AI, Conway K, Santella RM, Gammon MD (2017) Polycyclic aromatic hydrocarbons and postmenopausal breast cancer: an evaluation of effect measure modification by body mass index and weight change. Environ Res 152:17–25. https://doi.org/10.1016/j.envres.2016.09.022CrossRefPubMed

Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367–5374CrossRefPubMed

Pal A, Taneja N, Malhotra N, Shankar R, Chawla B, Awasthi AA, Janardhanan R (2021) Knowledge, attitude, and practice towards breast cancer and its screening among women in India: a systematic review. J Can Res Ther 17:1314–1321CrossRef

Parvin T, Das C, Choudhury M, Chattopadhyay BK, Mukhopadhyay M (2019) Prognostic utility of cyclin D1 in invasive breast carcinoma. Indian J Surg Oncol 10(1):167–173. https://doi.org/10.1007/s13193-018-0839-2CrossRefPubMed

Pepin KM, Ehman RL (2015) McGee KP Magnetic resonance elastography (MRE) in cancer: technique, analysis, and applications. Prog Nucl Magn Reson Spectrosc 90–91:32–48. https://doi.org/10.1016/j.pnmrs.2015.06.001CrossRefPubMed

Rajbongshi N, Mahanta LB, Nath DC, Sarma JD (2015) A matched case control study of risk indicators of breast cancer in Assam, India. Mymensingh Med J 24(2):385–391PubMed

Ram Prabu MP, Raina V, Shukla NK, Mohanti BK, Deo SVS (2011) A study of triple-negative breast cancer at a cancer institute in India. J Clin Oncol 29 :(suppl; abstr e11548)

Sandhu DS, Sandhu S, Karwasra RK, Marwah S (2010) Profile of breast cancer patients at a tertiary care hospital in north India. Indian J Cancer 47(1):16–22. https://doi.org/10.4103/0019-509X.58853CrossRefPubMed

Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB et al (2010) Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 11:165–173CrossRefPubMed

Sarkar DK, Jana D, Patil PS, Chaudhari KS, Chattopadhyay BK, Chikkala BR, Mandal S, Chowdhary P (2013) Role of NF-κB as a prognostic marker in breast cancer : a pilot study in Indian patients. Indian J Surg Oncol 4(3):242–247. https://doi.org/10.1007/s13193-013-0234-yCrossRefPubMedPubMedCentral

Saxena S, Szabo CI, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G, Goldgar DE, Bhatanager D (2002) BRCA1 and BRCA2 in Indian breast cancer patients. Hum Mutat 20:473–474CrossRefPubMed

Schoemaker MJ, Jones ME, Wright LB et al (2016) Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom. Breast Cancer Res. https://doi.org/10.1186/s13058-016-0733-1CrossRefPubMedPubMedCentral

Shanker N, Mathur P, Das P, Sathishkumar K, Shalini AJM, Chaturvedi M (2021) Cancer scenario in North-East India and need for an appropriate research agenda. Indian J Med Res 154(1):27–35. https://doi.org/10.4103/ijmr.IJMR_347_2CrossRefPubMedPubMedCentral

Sharma U, Jagannathan NR (2022) Magnetic resonance imaging (MRI) and MR spectroscopic methods in understanding breast cancer biology and metabolism. Metabolites 12(4):295. https://doi.org/10.3390/metabo12040295CrossRefPubMedPubMedCentral

Sharma M, Sharma JD, Sarma A, Ahmed S, Kataki AC, Saxena R, Sharma D (2014) Triple negative breast cancer in people of North East India: critical insights gained at a regional cancer centre. Asian Pac J Cancer Prev 15(11):4507–4511. https://doi.org/10.7314/APJCP.2014.15.11.4507CrossRefPubMed

Sharma JD, Khanna S, Ramchandani S et al (2021) Prevalence of molecular subtypes of breast carcinoma and its comparison between two different age groups: a retrospective study from a tertiary care center of Northeast India South Asian. J Cancer 10(4):220–224. https://doi.org/10.1055/s-0041-1731905ISSN2278-330XCrossRef

Singh M, Jangra B (2013) Association between body mass index and risk of breast cancer among females of north India. South Asian J Cancer 2(3):121–125. https://doi.org/10.4103/2278-330X.114108.PMID:24455581CrossRefPubMedPubMedCentral

Singh A, Pandey A, Tewari M, Pratyush D, Singh H, Pandey H et al (2011) Obesity augmented breast cancer risk: a potential risk factor for Indian women. J Surg Oncol 103(3):217–222. https://doi.org/10.1002/jso.21768CrossRefPubMed

Singh T, Veenu S, Kumar D, Gupt M, Singh G, Bal A (2017) Breast density in screening mammography in Indian population: is it different from western population? Breast J 24(3):365–368CrossRefPubMed

Singh S, Pal A, Srivastava NK, Thakur P (2018) Level of awareness and practices of women regarding breast cancer in Chhattisgarh, India: an institution based survey. Int J Med Public Health 8:145–151CrossRef

Sitia L, Sevieri M, Signati L, Bonizzi A, Chesi A, Mainini F, Corsi F, Mazzucchelli S (2022) HER-2-targeted nanoparticles for breast cancer diagnosis and treatment. Cancers (basel) 14(10):2424. https://doi.org/10.3390/cancers14102424CrossRefPubMed

Sun Y, Zhang J, Guo F et al (2016) Identification of apolipoprotein CI peptides as a potential biomarker and its biological roles in breast cancer. Med Sci Monit 22:1152CrossRefPubMedPubMedCentral

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. https://doi.org/10.3322/caac.21660CrossRefPubMed

Suresh P, Batra U, Doval DC (2013) Epidemiological and clinical profile of triple negative breast cancer at a cancer hospital in North India. Indian J Med Paediatr Oncol 34:89–95CrossRefPubMedPubMedCentral

Takalkar UV, Asegaonkar SB, Kulkarni U, Saraf M, Advani S (2016) Clinicopathological profile of breast cancer patients at a tertiary care hospital in Marathwada region of western India. Asian Pac J Cancer Prev 17:2195–2198CrossRef

Tayyab A (2021) Identification of non-invasive biomarkers for early detection of breast cancer: a review. J Clin Oncol Res Rep. https://doi.org/10.31579/2693-4787/017CrossRef

Uehiro N, Sato F, Pu F et al (2016) Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Breast Cancer Res 18:129. https://doi.org/10.1186/s13058-016-0788-zCrossRefPubMedPubMedCentral

Umetani N, Giuliano AE, Hiramatsu SH et al (2006) Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 24(26):4270–4276CrossRefPubMed

Vaidyanathan K, Lakhotia S, Ravishankar HM, Tabassum U, Mukherjee G, Somasundaram K (2009) BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation. J Biosci 34(3):415–422. https://doi.org/10.1007/s12038-009-0048-9CrossRefPubMed

Vennu V, Abdulrahman T, Bindawas S (2019) The prevalence of overweight, obesity, hypertension, and diabetes in India: analysis of the 2015–2016 National Family Health Survey. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph16203987CrossRefPubMedPubMedCentral

Villarreal-Garza C, Ferrigno AS, De la Garza-Ramos C, Barragan-Carrillo R, Lambertini M, Azim HA Jr (2020) Clinical utility of genomic signatures in young breast cancer patients: a systematic review. NPJ Breast Cancer 25(6):46. https://doi.org/10.1038/s41523-020-00188-3CrossRef

Vishwakarma G, Ndetan H, Das DN, Gupta G, Suryavanshi M, Mehta A, Singh KP (2019) Reproductive factors and breast cancer risk: a meta-analysis of case-control studies in Indian women. South Asian J Cancer 8(2):80–84. https://doi.org/10.4103/sajc.sajc_317_18CrossRefPubMedPubMedCentral

Vishwakarma G, Mehta A, Saifi M, Garg D, Paliwal D (2022) Modifiable (sleeping pattern and stress) and non-modifiable risk factors associated with breast cancer: a matched case-control study in Delhi. India Asian Pac J Cancer Prev 23(7):2469–2476. https://doi.org/10.31557/APJCP.2022.23.7.2469CrossRefPubMed

Wanders JO, Holland K, Veldhuis WB et al (2017) Volumetric breast density affects performance of digital screening mammography. Breast Cancer Res Treat 162(1):95–103CrossRefPubMed

Welch HG, Prorok PC, O’Malley AJ, Kramer BS (2016) Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med 375(15):1438–1447CrossRefPubMed

White E, Velentgas P, Mandelson MT et al (1998) Variation in mammographic breast density by time in menstrual cycle among women aged 40–49 years. J Natl Cancer Inst 90:906–910CrossRefPubMed

World Bank Country Classifications (2014). https://data.worldbank.org/about/country-classifications/country-and-lending-groups. Accessed 27 March 2014

Yambem LC, Rahman H (2019) Knowledge, attitudes, and beliefs about breast cancer and barriers to breast self-examination among Sikkimese women. Indian J Med Paediatr Oncol 40:175–181CrossRef

Zeeneldin AA, Mohamed AM, Abdel HA, Taha FM, Goda IA, AboDeef WT (2009) Survival effects of cyclooxygenase-2 and 12-lypooxygenase in Egyptian women with operable breast cancer. Indian J Cancer 46:54–60. https://doi.org/10.4103/0019-509X.48597CrossRefPubMed

Zheng X, Peng R, Jiang X, Wang Y, Xu S, Ke G, Fu T, Liu Q, Huan S, Zhang X (2017) Fluorescence resonance energy transfer-based dna nanoprism with a split aptamer for adenosine triphosphate sensing in living cells. Anal Chem 89:10941–10947CrossRefPubMed

Zheng Z, Wu L, Li L, Zong S, Wang Z, Cui Y (2018) Simultaneous and highly sensitive detection of multiple breast cancer biomarkers in real samples using a SERS microfluidic chip. Talanta 188:507–515. https://doi.org/10.1016/j.talanta.2018.06.013CrossRefPubMed

Titel: Breast cancer in young Indian women: factors, challenges in screening, and upcoming diagnostics
verfasst von: Pragyan Roy
Publikationsdatum: 08.08.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 15/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-023-05215-x

Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma

Open Access
Research

A novel model based on disulfidptosis-related genes to predict prognosis and therapy of bladder urothelial carcinoma

Research

Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study

Research

Liquid nitrogen frozen cells for chemotherapy drug delivery and vaccination of melanoma

Research

Integration of scRNA-seq and bulk RNA-seq constructs a stemness-related signature for predicting prognosis and immunotherapy responses in hepatocellular carcinoma

Research

Comment on “Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma”

Correspondence

Neu im Fachgebiet Onkologie

KI-gestütztes Mammografiescreening überzeugt im Praxistest

16.01.2025
Künstliche Intelligenz im Gesundheitswesen
Nachrichten

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Welche Krebserkrankungen bei Zöliakie häufiger auftreten

16.01.2025
Zöliakie
Nachrichten

Eine große Kohortenstudie hat den Zusammenhang zwischen Zöliakie und gastrointestinalen Krebserkrankungen und inflammatorischen Krankheiten untersucht. Neben gastrointestinalen Tumoren ist auch ein nicht solider Krebs häufiger.

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

15.01.2025
Urothelkarzinom
Nachrichten

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

15.01.2025
Melanom
Nachrichten

Im Vergleich zu den Überlebenschancen vor der Einführung von Immuncheckpointhemmern (ICI) ist der Fortschritt durch eine ICI-Kombination mit unterschiedlichen Tagets bei fortgeschrittenem Melanom erstaunlich. Das belegen die finalen Ergebnisse der CheckMate-067-Studie und geben Betroffenen "Hoffnung auf Heilung".

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Breast cancer in young Indian women: factors, challenges in screening, and upcoming diagnostics

Abstract

Graphical abstract

Weitere Artikel der Ausgabe 15/2023

Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma

A novel model based on disulfidptosis-related genes to predict prognosis and therapy of bladder urothelial carcinoma

Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study

Liquid nitrogen frozen cells for chemotherapy drug delivery and vaccination of melanoma

Integration of scRNA-seq and bulk RNA-seq constructs a stemness-related signature for predicting prognosis and immunotherapy responses in hepatocellular carcinoma

Comment on “Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma”

Neu im Fachgebiet Onkologie

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Welche Krebserkrankungen bei Zöliakie häufiger auftreten

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

Update Onkologie

Springer Medizin

Abstract

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten